Prenetics Global initiates FY2027 guidance for $400M+ IM8 revenue
Prenetics Global (NASDAQ: PRE) initiates FY2027 guidance, targeting $400 million+ in IM8 revenue.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.